The Efficacy and Safety of Sofosbuvir Containing Regimen in the Treatment of Hcv Infection in Patients with Haemoglobinopathy

Nawfal R Hussein
  • Nawfal R Hussein
    Department of internal Medicine, College of medicine, University of duhok, Iraq, | nawfal.hussein@yahoo.com

Keywords

HCV, Thalassaemia, sickle cell, sofosbuvir, DAA

Full Text:

PDF
HTML
Submitted: 2016-09-27 16:56:20
Published: 2017-01-01 00:00:00
Search for citations in Google Scholar
Related articles: Google Scholar

References

Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG, Barnes E. Global Distribution and Prevalence of Hepatitis C Virus Genotypes. Hepatology (Baltimore, Md) 2015;61(1):77-87.

Hui CK, Monto A, Belaye T, Lau E, Wright TL. Outcomes of interferon and ribavirin treatment for chronic hepatitis C in patients with normal serum aminotransaminases. Gut 2003;52(11):1644-1648.

Jazwinski AB, Muir AJ. Direct-Acting Antiviral Medications for Chronic Hepatitis C Virus Infection. Gastroenterology & Hepatology 2011;7(3):154-162.

Taherkhani R, Farshadpour F. Epidemiology of hepatitis C virus in Iran. World Journal of Gastroenterology : WJG 2015;21(38):10790-10810.

Barth H. Hepatitis C virus: Is it time to say goodbye yet? Perspectives and challenges for the next decade. World Journal of Hepatology 2015;7(5):725-737.

Mirmomen S, Alavian SM. Treatment of HCV Infection in Multitransfused Thalassemic Patients: Does Liver Iron Status Affect the Outcome of Response? Hepat Mon 2005;5(1):11-13.

Tabatabaei SV, Alavian SM, Keshvari M, Behnava B, Miri SM, Karimi Elizee P, Zamani F, Amini Kafiabad S, Gharehbaghian A, Hajibeigy B, Bagheri Lankarani K. Low Dose Ribavirin for Treatment of Hepatitis C Virus Infected Thalassemia Major Patients; New Indications for Combination Therapy. Hepat Mon 2012;12(6):372-381.

Hussein NR. Sofosbuvir-Containing Regimen for the Treatment of Hepatitis C Virus in a Patient With Sickle-Thalassemia: A First Case Report. International Journal of Infection 2016(Inpress).

Papadopoulos N, Deutsch M, Georgalas A, Poulakidas H, Karnesis L. Simeprevir and Sofosbuvir Combination Treatment in a Patient with HCV Cirrhosis and HbS Beta 0-Thalassemia: Efficacy and Safety despite Baseline Hyperbilirubinemia. Case Reports in Hematology 2016;2016:4.

Abstract views:
329

Views:
PDF
96
HTML
256

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2016 Mediterranean Journal of Hematology and Infectious Diseases

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Ā 

The Mediterranean Journal of Hematology and Infectious Diseases [eISSN 2035-3006] is owned by the U.C.S.C. and it is published by PAGEPressĀ®, Pavia, Italy. All credits and honors to PKP for their OJS.
 
 
© PAGEPress 2008-2017     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185